Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA7 | P43166 | 5/20 | 0.43 |
| ▸ | CA9 | Q16790 | 5/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.43 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27522860 | 0.73 | CA12 (0.33) | CA12CA1CA2CA9CA14 | |
| SCHEMBL27625055 | 0.73 | CA1 (0.40) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16606258 | 0.67 | CA12 (0.75) | CA12CA1CA2CA7CA9 | |
| SCHEMBL701832 | 0.67 | CA12 (0.83) | CA12CA1CA2CA7CA9 | |
| SCHEMBL818551 | 0.66 | KDM4E (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27667925 | 0.65 | CA12 (0.79) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28761675 | 0.65 | CA12 (0.79) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27667912 | 0.65 | CA12 (0.79) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27647565 | 0.65 | CA12 (0.79) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27667911 | 0.65 | CA12 (0.79) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104151312-A | Inhibitors of influenza viruses replication | VERTEX PHARMA | 2014-11-19 | — | — | CN | disclosed |
| CN-103724343-A | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof | MEMORY PHARM CORP | 2014-04-16 | — | — | CN | disclosed |
| CN-101679366-B | Pyridyl piperidine orexin receptor antagonists | MERCK & CO INC | 2013-08-07 | — | — | CN | disclosed |
| CN-101558040-B | Dihydropyridine derivatives useful as protein kinase inhibitors | BAYER SCHERING PHARMA AG | 2013-03-27 | — | — | CN | disclosed |
| CN-102942520-A | P38 map kinase inhibitors | CHROMA THERAPEUTICS LTD | 2013-02-27 | — | — | CN | disclosed |
| CN-101595084-B | Diaryl compositions and methods for modulating kinase cascades | KINEX PHARMACEUTICALS LLC US | 2013-01-02 | — | — | CN | disclosed |
| CN-102516241-A | CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives | ABBOTT LAB | 2012-06-27 | — | — | CN | disclosed |
| CN-101454010-B | Antifungal agents | MERCK & CO INC | 2012-06-20 | — | — | CN | disclosed |
| CN-1612861-B | ECL labels with improved non-specific binding properties, methods of use thereof and kits comprising the same | BIOVERIS CORP | 2011-09-14 | — | — | CN | disclosed |
| CN-1819996-B | Naphthylene derivatives as cytochrome P450 inhibitors | OSI PHARM INC | 2010-10-27 | — | — | CN | disclosed |
| CN-1894226-A | Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use | WYETH CORP (US) | 2007-01-10 | — | — | CN | disclosed |
| CN-1867546-A | Novel compound and its uses in medicine, its preparation method and its pharmaceutical composition comprising same | REDDY RES FOUNDATION (IN) | 2006-11-22 | — | — | CN | disclosed |
| CN-1819996-A | Naphthylene derivatives as cytochrome P450 inhibitors | OSI PHARM INC (US) | 2006-08-16 | — | — | CN | disclosed |
| CN-1738793-A | Compounds, compositions and methods | CYTOKINETICS INC (US) | 2006-02-22 | — | — | CN | disclosed |
| CN-1229331-C | Inhibitors of monoamine uptake | LILLY CO ELI (US) | 2005-11-30 | — | — | CN | disclosed |
| CN-1612861-A | ECL labels with improved non-specific binding properties, methods of use thereof and kits comprising the same | IGEN INT INC (US) | 2005-05-04 | — | — | CN | disclosed |
| CN-1494526-A | Inhibitors of monoamine uptake | — | 2004-05-05 | — | — | CN | disclosed |
| CN-1137122-C | Heterocyclic compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them | 雷迪实验室有限公司 | 2004-02-04 | — | — | CN | disclosed |
| CN-1407975-A | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-04-02 | — | — | CN | disclosed |
| CN-1221416-A | Heterocyclic compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them | REDDY RESEARCH FOUNDATION (IN) | 1999-06-30 | — | — | CN | disclosed |